SCHEMBL4615204

SCHEMBL4615204

COC(=O)CCc1ccc(Oc2ccccc2CN)cc1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.45
SLC6A4 P31645 1/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP3A5 P20815 1/20 0.41
CYP2C19 P33261 1/20 0.41
FFAR1 O14842 2/20 0.40
FFAR4 Q5NUL3 1/20 0.40
PPARD Q03181 5/20 0.39
PPARG P37231 4/20 0.39
PPARA Q07869 4/20 0.39
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
P2RY10 O00398 1/20 0.38
HRH1 P35367 1/20 0.37
REN P00797 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515886 0.84 PPARG (0.44) HTR2ASLC6A4MEN1KMT2AFFAR1
SCHEMBL4614641 0.81 CYP4F2 (0.49) HTR2ASLC6A4P2RY10HRH1
SCHEMBL4615129 0.81 PPARG (0.49) MEN1KMT2AFFAR1FFAR4PPARD
SCHEMBL4516434 0.80 PPARG (0.45) HTR2ASLC6A4MEN1KMT2AFFAR1
SCHEMBL4614901 0.78 PPARD (0.43) MEN1KMT2AFFAR1FFAR4PPARD
SCHEMBL5704455 0.78 PPARG (0.48) MEN1KMT2AFFAR1FFAR4PPARD
SCHEMBL4614607 0.78 PPARG (0.40) MEN1KMT2AFFAR1FFAR4PPARD
SCHEMBL63388 0.78 KMT2A (0.55) MEN1KMT2A
SCHEMBL4616403 0.77 PPARG (0.41) HTR2ASLC6A4MEN1KMT2AFFAR1
SCHEMBL4516207 0.77 PPARG (0.45) MEN1KMT2ACYP3A4FFAR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697304-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2008-02-20 EP disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
EP-1697304-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2006-09-06 EP disclosed
WO-2005054176-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082907-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD HTR2A 2517/4885SLC6A4 2959/4885MEN1 4826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.